This review will focus on the role and regulation of FOXO3 and its key downstream target FOXM1, and discuss their central roles as modulators of fundamental cellular processes with special emphasis on our understanding of the current therapeutic potential of targeting the FOXO3-FOXM1 axis in cancer. This evidence concerns the gene FOXO3 and cancer.